Search

everythinglearnresearchcommunity

for

Search:↓

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

The health of the area receiving a transplant affects the survival of the tiny grafts.

Surgical excision is the best treatment for SCC.

Kidney transplant patients often have skin issues, mainly infections.

Many Iraqi patients had skin problems at the site where a vein was taken for heart surgery.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

A kidney transplant patient developed pink skin bumps with spiny centers on her face and limbs.

Recognizing and treating overlap syndrome in connective tissue diseases is crucial.

A fungal skin infection was successfully treated with medication and compression therapy.

Squaric acid dibutylester for alopecia areata can cause benign skin lymphoid growths.

Early recognition and treatment of VATS in transplant patients improve outcomes.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Silk sericin dressing with collagen heals wounds faster and improves scar quality better than Bactigras.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.

Herpes zoster can cause lasting nail and hair damage.

The patient improved after antiviral treatment for a viral infection.

Mogamulizumab can cause hair loss and skin rashes.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

A rare type of skin lymphoma was identified, affecting hair follicles and sweat glands.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Switching immunosuppressive drugs can improve hair regrowth and well-being in transplant patients with hair loss.